Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity.

Maity, Subhasish; Santra, Ayantika; Hebbani, Ananda Vardhan; Pulakuntla, Swetha; Chatterjee, Ankita; Badri, Kameswara Rao; Damodara Reddy, Vaddi

Maity, Subhasish; Santra, Ayantika; Hebbani, Ananda Vardhan; Pulakuntla, Swetha; Chatterjee, Ankita; Badri, Kameswara Rao; Damodara Reddy, Vaddi.

Afiliação

Maity S; Department of Biotechnology, REVA University, Bengaluru 560064, Karnataka, India.
Santra A; Department of Biochemistry, Indian Academy Degree College, Bengaluru 560 043, India.
Hebbani AV; Department of Biochemistry, Indian Academy Degree College, Bengaluru 560 043, India.
Pulakuntla S; Department of Biotechnology, REVA University, Bengaluru 560064, Karnataka, India.
Chatterjee A; Department of Biotechnology, REVA University, Bengaluru 560064, Karnataka, India.
Badri KR; Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Morehouse School of Medicine, GA, Atlanta 30310, USA; Clinical Analytical Chemistry Laboratory, COVID-19 Testing Laboratory, Morehouse School of Medicine, GA, Atlanta 30310, USA. Electronic address: kbadri@msm.edu.
Damodara Reddy V; Department of Biotechnology, REVA University, Bengaluru 560064, Karnataka, India. Electronic address: damodara.reddyv@reva.edu.in.

Gene ; 881: 147612, 2023 Sep 25.

Article em En | MEDLINE | ID: mdl-37423400

Assuntos

COVID-19; SARS-CoV-2; Humanos; Virulência; Citocinas; Antivirais/uso terapêutico

Palavras-chave

COVID-19 Disease; Cytokine storm; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Gene Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google